Niva Bupa Health Insurance Company

    NIVABUPA
    Insurance
    ₹73.80
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹13,658 Cr

    P/E
    25.71
    Day range
    ₹72.75 – ₹76.01
    52-week range
    ₹67.50 – ₹91.40
    Volume
    20.58 L
    Open
    ₹75.99
    Prev close
    ₹75.59

    Latest results · Q2 FY27(consolidated)Revenue ₹2,412 Cr+58.7%Profit ₹136 CrMargin 5.6%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 59 / 100

    Factor percentiles

    Value74
    Quality26
    Momentum40
    Low volatility95

    Derived metrics

    Earn. yield
    3.9%
    12-1 mom.
    -0.1%
    Return / vol
    -0.12
    FCF yield
    6.3%

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 11 in Insurance
    Largest Insurance companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Life Insurance CorpLICI₹2.53 L Cr8.152.6737.8%35.0%4.1%0.00+9.9%
    SBI Life InsuranceSBILIFE₹1.79 L Cr67.57—13.7%15.0%2.3%0.00+6.5%
    HDFC Life InsuranceHDFCLIFE₹1.25 L Cr60.776.6111.3%10.0%1.4%0.16+18.3%
    ICICI Lombard GICICICIGI₹82,272 Cr32.344.4917.8%22.0%15.0%0.00+19.7%
    ICICI Life InsuranceICICILIFE₹64,485 Cr36.694.8512.6%10.0%-24.0%0.19-79.7%
    General Insurance Corporation of IndiaGICRE₹59,413 Cr6.620.8014.6%17.0%23.0%0.00+17.5%
    Max Financial ServicesMFSL₹49,034 Cr264.588.602.0%3.0%1.2%0.35+18.5%
    Niva Bupa Health Insurance CompanyNIVABUPA₹13,658 Cr25.71—3.5%3.0%7.0%0.07+25.5%
    Sector median₹59,413 Cr32.344.6711.3%10.0%2.3%0.01+17.1%

    Sector as classified in the tracked universe; medians use every tracked Insurance company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 2h ago

    Headlines about Niva Bupa Health Insurance Company from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    ROE (FY26)
    3.5%
    ROCE (latest year)
    3%

    Moving averages (NSE)

    20-day
    ₹74.59
    Price below
    50-day
    ₹76.69
    Price below
    200-day
    ₹79.42
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +32.9%
    Profit 3Y CAGR
    +116.0%
    Revenue YoY (Sep 2026 (S))
    +25.5%
    Profit YoY (Sep 2026 (S))
    +123.0%
    Operating margin
    7.0%
    Net margin
    5.3%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    -1K Cr0 Cr1K Cr2K Cr3K Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023 (S)Jun 2024 (S)Dec 2024 (S)Jun 2025 (S)Dec 2025 (S)Sep 2026 (S)-15%0%15%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • DII
    • Public
    • FII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2019 (S)Mar 2020 (S)Mar 2021 (S)Mar 2022 (S)Mar 2023 (S)Mar 2024 (S)Mar 2025 (S)Mar 2026 (S)-4K Cr-2K Cr0 Cr2K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY20FY21FY22FY23FY24FY25FY26-40%-20%0%20%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr1K Cr2K Cr3K Cr4K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2019 (S)Mar 2020 (S)Mar 2021 (S)Mar 2022 (S)Mar 2023 (S)Mar 2024 (S)Mar 2025 (S)Sep 2026 (S)0x0.5x1x

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023 (S)Mar 2024 (S)Jun 2024 (S)Sep 2024 (S)Dec 2024 (S)Mar 2025 (S)Jun 2025 (S)Sep 2025 (S)Dec 2025 (S)Mar 2026 (S)Jun 2026 (S)Sep 2026 (S)
    Sales1,0261,3161,1241,3211,2581,6711,9322,0491,6112,2512,4712,572
    Expenses1,0711,2151,2281,3871,2821,4201,8341,9671,7052,0692,2872,389
    Operating Profit-46100-103-66-242519882-94182184183
    OPM %-4.4%8%-9%-5%-1.9%15%5%4%-6%8%7%7%
    Other Income5057847937-45007-10-2
    Interest000000000000
    Depreciation000000000000
    Profit before tax5157-1913132069882-88181184182
    Tax %0%0%0%0%0%0%27%26%0%12%25%25%
    Net Profit5157-1913132067161-88159138136
    EPS in Rs————₹0.07₹1.13₹0.39₹0.33₹-0.47₹0.86₹0.75₹0.73

    From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days0

    0 days since Mar 2021 (S)

    Cash Conversion Cycle0

    0 days since Mar 2021 (S)

    Working Capital Days-354

    -64 days since Mar 2021 (S)

    Strengths, risks & growth

    Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India. [1]

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter55.36%55.36%55.30%55.29%-0.01 pp
    FII10.31%10.60%12.09%12.95%+0.86 pp
    DII16.04%16.49%16.17%15.89%-0.28 pp
    Public18.27%17.56%16.44%15.88%-0.56 pp

    Filed with NSE for Sept 2026: promoters 55.29%, public 44.71%

    Analysts & fund holdings

    91%
    91% recommend buy
    11 analysts cover the stock
    Valuation vs Insurance
    P/E25.7 vs 18.1
    Sector P/B2.29

    Who holds the shares, quarter by quarter

    Mutual funds 9.19% (-0.16 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters55.3%
    • Foreign institutions12.9%
    • Mutual funds9.2%
    • Insurance0.9%
    • Other domestic institutions5.8%
    • Retail1.8%
    • Others14.1%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Nippon India Multi Cap Fund2.62%0.72%-0.08 pp
    Axis Small Cap Fund1.31%0.64%-0.11 pp
    DSP Small Cap Fund0.89%0.63%-0.13 pp
    SBI ELSS Tax Saver Fund0.82%0.39%-0.04 pp
    SBI Banking & Financial Services Fund0.46%0.63%-0.10 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Avg
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    23.9%
    Downside volatility
    22.9%
    Worst 5% of days
    2.4%
    Average of that tail
    3.1%
    Max drawdown (1Y)
    19.8%
    Below its peak
    16.5%

    Against the market

    Beta vs Nifty 50
    0.27
    Correlation
    0.15
    Relative strength (3M)
    -14.6%
    ATR (14)
    3.3%

    Return

    Return 1M
    -2.8%
    Return 3M
    -10.8%
    Return 6M
    -7.7%
    Return 1Y
    -2.9%
    vs 200-day average
    -7.1%

    Momentum

    RSI (14)
    43.2
    MACD histogram
    0.21
    Stochastic %K
    30.3
    ADX (14)
    25.3
    +DI / −DI
    24.5 / 22.4
    Money flow index
    68.4

    Participation

    Delivery (20d avg)
    62.2%
    vs its 60-day baseline
    +6.1 pts
    Volume vs 20-day
    +0.6σ
    Close vs day's VWAP
    +0.2%
    52-week position
    27 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.

    Free cash flow
    ₹856 Cr
    FCF yield
    6.3%
    Net debt
    ₹177 Cr
    Net debt / equity
    0.05
    EV / sales
    1.66
    Revenue CAGR
    58.7%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Corporate actions

    No dividends, splits or bonuses recorded for this company yet.

    Company announcements

    AGM/EGM
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Postal ballot notice along with Explanatory statement

    Company Update
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update
    Completion Of Redemption Of Debentures At Par, Pursuant To Exercise Of Call Option And Payment Of Interest Thereon

    Completion of redemption of Debentures at par, pursuant to exercise of call option and payment of interest thereon.

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation - Participation in Investor Conferences

    Company Update
    Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    Transcript of Earnings Call held on November 04, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Submission of Newspaper Publication

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    The Company has informed about the link of audio recording.

    Company Update
    Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Press Release on unaudited financial results for the quarter and half year ended September 30, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

    Amendments to the PIT Policies

    Company Update
    Announcement under Regulation 30 (LODR)-Investor Presentation

    Investor Presentation for the Earnings call scheduled today i.e. November 04, 2026.

    Board Meeting
    Board Meeting Outcome for Outcome Of Board Meeting Held On November 04, 2026

    Outcome of Board meeting held on November 04, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    Allotment of 9,89,450 Equity shares.

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Earning Call for the quarter and half year ended September 30, 2026

    Board MeetingPrice-sensitive
    Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter And Half-Year Ended September 30, 2026.

    Niva Bupa Health Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited ....

    Company Update
    Announcement under Regulation 30 (LODR)-Demise

    Cessation of Mr. Roger William John Davis, Non-executive Director of the Company w.e.f. October 17, 2026.

    Filed with BSE (scrip 544286); the last 45 days. Documents open at bseindia.com.

    Documents

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 4 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Niva Bupa Health Insurance Company: common questions

    Answered from the figures on this page.

    Niva Bupa Health Insurance Company last traded at ₹73.80 (NSE, as of 18 Nov 2026). The last session moved it down 2.37%.

    Niva Bupa Health Insurance Company is valued at about ₹13,658 crore (NSE, as of 18 Nov 2026).

    Niva Bupa Health Insurance Company trades at a price-to-earnings ratio of 25.71 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Niva Bupa Health Insurance Company has traded between ₹67.50 and ₹91.40 over the past 52 weeks, to 18 Nov 2026. It is currently 26% of the way up that range.

    Niva Bupa Health Insurance Company (NIVABUPA) is classified under Insurance on this site's screener.